0001093557-15-000072.txt : 20150311
0001093557-15-000072.hdr.sgml : 20150311
20150311194357
ACCESSION NUMBER: 0001093557-15-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150308
FILED AS OF DATE: 20150311
DATE AS OF CHANGE: 20150311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VALDES JORGE A
CENTRAL INDEX KEY: 0001343856
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 15694127
MAIL ADDRESS:
STREET 1: C/O DEXCOM INC
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-03-08
0
0001093557
DEXCOM INC
DXCM
0001343856
VALDES JORGE A
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
CTO
Common Stock
2015-03-08
4
A
0
45000.0
0.0010
A
163748
D
Common Stock
2015-03-08
4
J
0
11937.0
59.59
D
151811
D
Common Stock
2015-03-08
4
J
0
23667.0
59.59
D
128144
D
Common Stock
2015-03-09
4
M
0
8244.0
13.45
A
136388
D
Common Stock
2015-03-09
4
S
0
8244.0
58.7735
D
128144
D
Common Stock
2015-03-08
4
J
0
11937.0
59.59
A
85620
I
by Trust
Common Stock
2015-03-08
4
J
0
23667.0
59.59
A
109287
I
by Trust
Common Stock
2015-03-09
4
S
0
5712.0
59.2446
D
103575
I
by Trust
Common Stock
2015-03-09
4
S
0
926.0
59.87
D
102649
I
by Trust
Non-Qualified Stock Option (right to buy)
13.45
2015-03-09
4
M
0
8244.0
58.7735
D
2006-11-01
2015-11-01
Common Stock
8244
24731
D
Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
Included in this number are 128,144 unvested restricted stock units, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 47,333 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 35,811 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units.
On November 10, 2014, Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $58.45 to $59.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
This transaction was executed in multiple trades at prices ranging from $59.23 to $59.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
By: Jess Roper For: Jorge A. Valdes
2015-03-11